Search
Aquestive Therapeutics Inc
AQSTAdd to Watchlist
3.610USD
-0.050-1.37%
Close 11-06 16:00（ET）
453.09MMarket Cap
LossP/E TTM
Today
-1.37%
5 Days
-7.20%
1 Month
-21.69%
6 Months
-14.66%
Year to Date
-44.12%
1 Year
-41.11%
Key Figures
3.710Open
3.760High
473.14KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.38%Turnover Ratio
3.660Prev. Close
3.670Low
1.71MTurnover
LossP/E Static
-6.41P/B
0.00%Div Yield TTM
-56.63%ROA
6.73552wk High
0.19Volume Ratio
-44.14MNet Profit
125.51MShares
-0.6092EPS TTM
1.46Beta
--ROE
2.93052wk Low
8.06%Amplitude
69.04%Gross Margin
453.09MMarket Cap
2.20Reward/Risk
4.86%Risk Rate
Recent
Transcripts
Aquestive Therapeutics Inc's Score
-0.01vs previous score
Forecast8.44
Financial Health5.53
Technical4.68
Valuation Dimensions8.83
Institutional Confidence5.00
Risk Assessment4.90
Media Coverage
Coverage Level
Very Low
Very High
Negative-
Analyst Rating
Aquestive Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Aquestive Therapeutics Inc Latest Earnings Call Transcripts
Aquestive Therapeutics (AQST) Q3 2026 Earnings Call: Anaphylm FDA Review and $90.3M Cash
Aquestive Therapeutics Q3 2026 earnings call: Anaphylm awaits a March 2027 FDA decision, cash reached $90.3 million, and guidance was maintained.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.13/-0.12
Revenue / Forecast
7.56M/11.02M
Aquestive Therapeutics Inc Profile
SectorPharmaceuticals
Ticker SymbolAQST
Number of employees142
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Crestline Investors, Inc. | 7.89% |
| BlackRock Institutional Trust Company, N.A. | 5.57% |
| RTW Investments L.P. | 5.03% |
| Federated MDTA LLC | 2.27% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor/Hedge Fund | 17.04% |
| Hedge Fund | 16.74% |
| Investment Advisor | 12.97% |
| Research Firm | 4.88% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Aquestive Therapeutics Inc (AQST)?
The current price of Aquestive Therapeutics Inc (AQST) is 3.61.
What is the symbol of Aquestive Therapeutics Inc?
The ticker symbol of Aquestive Therapeutics Inc is AQST.
What is the 52-week high of Aquestive Therapeutics Inc?
The 52-week high of Aquestive Therapeutics Inc is 6.85.
What is the 52-week low of Aquestive Therapeutics Inc?
The 52-week low of Aquestive Therapeutics Inc is 2.93.
What is the market capitalization of Aquestive Therapeutics Inc?
The market capitalization of Aquestive Therapeutics Inc is 453.09M.
Is Aquestive Therapeutics Inc (AQST) currently rated as Buy, Hold, or Sell?
According to analysts, Aquestive Therapeutics Inc (AQST) has an overall rating of Buy, with a price target of 9.33.
What is the Earnings Per Share (EPS TTM) of Aquestive Therapeutics Inc (AQST)?
The Earnings Per Share (EPS TTM) of Aquestive Therapeutics Inc (AQST) is -0.61.